MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $5,000 | -28.6% | 250 | -53.1% | 0.00% | – |
Q3 2020 | $7,000 | -53.3% | 533 | -50.8% | 0.00% | -100.0% |
Q1 2020 | $15,000 | -48.3% | 1,083 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $29,000 | +93.3% | 1,083 | +104.3% | 0.00% | +100.0% |
Q3 2019 | $15,000 | 0.0% | 530 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $15,000 | +87.5% | 530 | +112.0% | 0.00% | 0.0% |
Q1 2019 | $8,000 | +14.3% | 250 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $7,000 | -41.7% | 250 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $12,000 | -64.7% | 250 | -68.4% | 0.00% | -66.7% |
Q2 2018 | $34,000 | +17.2% | 790 | -20.2% | 0.00% | +50.0% |
Q1 2018 | $29,000 | -14.7% | 990 | 0.0% | 0.00% | -33.3% |
Q4 2017 | $34,000 | -5.6% | 990 | 0.0% | 0.00% | -25.0% |
Q3 2017 | $36,000 | -7.7% | 990 | -33.6% | 0.00% | -20.0% |
Q2 2017 | $39,000 | +21.9% | 1,490 | -11.8% | 0.01% | 0.0% |
Q1 2017 | $32,000 | -84.6% | 1,690 | -83.3% | 0.01% | -87.2% |
Q3 2016 | $208,000 | -65.3% | 10,115 | -48.4% | 0.04% | -71.3% |
Q2 2016 | $600,000 | -11.9% | 19,600 | +7.7% | 0.14% | -26.9% |
Q1 2016 | $681,000 | -6.1% | 18,205 | +8.4% | 0.19% | -20.2% |
Q4 2015 | $725,000 | +20.8% | 16,789 | +4.8% | 0.23% | +28.7% |
Q3 2015 | $600,000 | +27.9% | 16,015 | +17.4% | 0.18% | +31.2% |
Q2 2015 | $469,000 | +8.3% | 13,645 | +10.5% | 0.14% | +15.0% |
Q1 2015 | $433,000 | +1.6% | 12,345 | +10.0% | 0.12% | -9.8% |
Q4 2014 | $426,000 | +27.9% | 11,220 | +29.8% | 0.13% | +9.0% |
Q3 2014 | $333,000 | – | 8,645 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |